Acorda Therapeutics Inc

ACOR 
(NASDAQ) 
 
$ 23.70 <%= Resources.Global.txtDown %>
Updated 18/05/2018
Change % -1.86% Stock price decreasing
Change -0.45 Stock price decreasing
Volume 50,946
High $ 24.20
Low $ 23.45
Open $ 24.20
ISIN
Prev close $ 24.15
# of shares 47.07M
Market cap 1,115.48M USD
Intraday

Market closed
Acorda Therapeutics Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  23.70 -2.7% Stock price decreasing 1.5% Stock price increasing -6.3% Stock price decreasing 21.5% Stock price increasing 55.4% Stock price increasing
Powered by TradingView

News about Acorda Therapeutics Inc

  • English
  • Regulatory news
15 May
 
31 Jan
 
17 Jan
 
11 Jan
 
06 Jan
 
04 Jan
 
03 Jan
 
21 Dec
 
19 Dec
 
18 Dec
 

Company profile

Acorda Therapeutics is a biotechnology company that identifies, develops, and commercializes novel therapies for neurological disorders. Acorda uses scientific, clinical, and commercial expertise in neurology as strategic points of access in additional nervous system markets, including stroke, Parkinson's disease, and epilepsy. The company does not operate separate lines of business with respect to any of its products or product candidates. All of its net product revenue is derived from the United States.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
20 May 2018 12:54:15
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180515.2 - EUROWEB4 - 2018-05-20 13:54:15 - 2018-05-20 12:54:15 - 1000 - Website: OKAY